The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Current progress, challenges and future prospects of diagnostic and therapeutic interventions in Alzheimer's disease
Open accessAbstract
The diverse pathological mechanisms and their implications for the development of effective diagnostic and therapeutic interventions in Alzheimer's disease are presented with current progress, challenges and future prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various growing factors for AD like presenelin 1 proteins, oxidative stress, tau neurofibrillary tangles can cause dysfunction of autophagic vacuoles and hence can contribute in the pathogenesis of AD [32, 33].”
From Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease (2020) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,975
Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D. A., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,154
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
The global prevalence of dementia: a systematic review and metaanalysis.
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.007 · Cited by 4,941
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods
Jack, C. R., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G., Harvey, D., Borowski, B., Britson, P. J., L. Whitwell, J., Ward, C., et al. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21049 · Cited by 4,347
Autophagy: cellular and molecular mechanisms
Glick, D. R., Barth, S., & Macleod, K. F. (2010) · The Journal of Pathology · doi:10.1002/path.2697 · Cited by 3,995
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Flagged first, then by citations
Research works printed but not linked: 7
- Steele, 2013, Postdoc J., 1, 21
- Newberg, 2006, J. Nucl. Med., 47, 748
- Hung, 2017, J. Biomed. Sci., 24, 47, 10.1186/s12929-017-0355-7 · DOI · Paper page
- Mark, 2002, Curr. Opin. Drug Discovery Dev., 2, 417
- Guo, 2013, Neural Regener. Res., 8, 2003
- Zhang, 2014, Front. Cell. Neurosci., 8, 427
- Dolan, 2010, Curr. Opin. Drug Discovery Dev., 13, 595
Cited by
Sorted by citations
Items 101–154 of 154
Elseweidy, M. M., Mahrous, M., Ali, S. I., Shaheen, M. A., & Younis, N. N. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02449-x · Cited by 6
RetractedBreaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Shekho, D., Mishra, R., Kamal, R., Bhatia, R., & Awasthi, A. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02923-6 · Cited by 6
Xu, S., Wang, W., Dong, X., & Sun, Y. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00502 · Cited by 6
Kumar, A., Mondal, T., Ramesh, M., Bhoi, J., Samanta, S., & Govindaraju, T. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00998 · Cited by 6
Self-citationBukhari, S. N. A., & Yogesh, R. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220405232333 · Cited by 5
Cognition Enhancing Potential of Aqueous Leaf Extract of Amaranthus dubius in Mice
Kipkemoi, D. J., Ireri, A. M., & Ngugi, M. P. (2023) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x231211661 · Cited by 5
Xu, J., Sun, Y., Zhu, X., Pan, S., Tong, Z., & Jiang, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31256 · Cited by 8
Investigation of Some Metabolic Enzyme Inhibition Properties of Novel Chalcone‐Cu Complexes
Ebiri, R., Turgut, M., Anıl, D. A., Demir, Y., Sağlamtaş, R., Alagöz, M. A., Algül, Ö., & Burmaoğlu, S. (2024) · ChemistrySelect · doi:10.1002/slct.202401093 · Cited by 5
Phyto-nanotechnology: A novel beneficial strategy for Alzheimer's disease therapy
Ganguly, S. C., Sangram, S., Paul, S., & Kundu, M. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105868 · Cited by 5
Gabr, M. T., & Murugan, N. A. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127370 · Cited by 7
Multifaceted Therapy of Nanocatalysts in Neurological Diseases
Wang, H., Chen, X., Mao, M., & Xue, X. (2021) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2021.3063 · Cited by 5
Kumar, A., Ramesh, M., Bhoi, J., & Govindaraju, T. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03360 · Cited by 4
Self-citationAdaptable nanoparticles as multifunction semi-transparent conductive films and drug delivery system
Fares, M. M., & Radaydeh, S. K. (2023) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2023.101079 · Cited by 4
Cooperative dissolution of peptidomimetic vesicles and amyloid β fibrils
Dinda, S., Ghosh, D., & Govindaraju, T. (2024) · Nanoscale · doi:10.1039/d3nr04847k · Cited by 3
Self-citationDeorankar, P. S., Minglani, V. V., Prajapati, B. G., & Patel, M. B. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273335978250127070434 · Cited by 3
Chinnathambi, S. (2024) · Cellular Physiology and Biochemistry · doi:10.33594/000000693 · Cited by 3
Xu, Z., Tang, J., & Yi, W. (2024) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2024.103065 · Cited by 3
Gupta, A., Ghosh, A., Sharma, N., & Gorain, B. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05003-3 · Cited by 4
The impact of pharmacological agents on neuroinflammation in neurodegenerative diseases
Sharma, A., Khan, Z., Nath, R., & Dixit, R. (2025) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2025-0018 · Cited by 4
Zhang, H., Sang, J., Li, L., Jiang, L., Lu, F., He, S., Cui, W., Zhang, X., & Liu, F. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1799863 · Cited by 3
Dihydrophthalazinediones accelerate amyloid β peptide aggregation to nontoxic species
Ghosh, D., SAMANTA, S., & Govindaraju, T. (2020) · Bulletin of Materials Science · doi:10.1007/s12034-020-02223-2 · Cited by 3
Self-citationBrain targeting drug delivery systems for the management of brain disorders
Kaur, M., Sodhi, R. K., Jyothi, V. G. S. S., Sree, V. H., Shubhra, Singh, P. K., Mehra, N. K., Khatri, D. K., Srivastava, S., Singh, S. B., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85041-4.00012-3 · Cited by 4
Microbubbles-based drug delivery for antiAlzheimer's drugs
Patel, M. B., Prajapati, B. G., & Yadav, M. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00006-6 · Cited by 3
Kim, J., Jeong, S., Jeon, J., & Suk, H. (2024) · International Winter Conference on Brain-Computer Interface (BCI) · doi:10.1109/bci60775.2024.10480470 · Cited by 3
Lin, X., Xu, T., Hou, W., Dong, X., & Sun, Y. P. (2024) · Molecules · doi:10.3390/molecules29215023 · Cited by 3
Ford, J., Kafetsouli, D., Wilson, H., Udeh‐Momoh, C. T., Politis, M., Ahmadi‐Abhari, S., Rabiner, I., & Middleton, L. T. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.7 · Cited by 3
Onifade, O. F., Abodunrin, O. P., Oyeneye, E. O., Chigozie, E. G., Arafa, A. G., & Okunlola, B. O. (2025) · Medicine in Omics · doi:10.1016/j.meomic.2025.100044 · Cited by 2
Amyloid β Aggregate-Sensitive Red Fluorescent Dipolar Probes
Kim, H., Parida, R., Youn, K., Shin, S. C., Keum, G., Lee, J. Y., Bang, E., & Yoo, S. (2023) · ACS Applied Optical Materials · doi:10.1021/acsaom.3c00159 · Cited by 2
Khan, K. A., Esa, M., Kamal, Z., Ullah, B., Perry, G. L., Kamal, S., Ahmad, S., Hussain, H., Ullah, A., & Shafique, M. S. (2025) · Current Neuropharmacology · doi:10.2174/011570159x361867250313073624 · Cited by 2
Değirmenci, U., & Ezer, T. (2024) · Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi · doi:10.31020/mutftd.1479130 · Cited by 2
Hu, Z., Zhou, S., Li, J., Li, X., Zhou, Y., Zhu, Z., Xu, J., & Liu, J. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0206 · Cited by 1
Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
ÖZGEN, A. O., & Eyüpoğlu, O. E. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010009 · Cited by 1
Kahil, E. A., Jackson, A., D’Souza, B., Gorman, G. S., & Jumbo‐Lucioni, P. P. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2477226 · Cited by 1
The science of Alzheimer’s disease: Current research, therapies, and hope for the future
Recharla, M. (2025) · doi:10.70593/978-81-988918-4-6_2 · Cited by 1
Das, T., Das, S., Das, S. R. C., Ghose, S., Das, A., Chowdhury, S., Chakraborty, P., Kar, K., & Sharma, N. (2025) · NeuroMarkers. · doi:10.1016/j.neumar.2025.100131 · Cited by 2
Malpani, P., Rana, M., Morda, U., & Sharma, A. K. (2026) · ChemistrySelect · doi:10.1002/slct.202504275 · Cited by 1
Phullay, P., Panwar, R., Bajwa, S., Wadhwa, K., Chauhan, P., Pahwa, R., Kriplani, P., Rajak, H., Awasthi, R., & Dureja, H. (2026) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-026-00616-z · Cited by 1
Zhenhui, 张. Z., Erqi, 王. W., & Yujiao, 石. S. (2022) · Infrared and Laser Engineering · doi:10.3788/irla20220541 · Cited by 1
Innate and adaptive glial cell responses in Alzheimer’s disease
Singh, A., & Singh, T. R. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00039 · Cited by 1
Aspectos clínicos e moleculares do Alzheimer – revisão de literatura
Mota, W. Q., Lobão, I. D. S., da Cunha, J. V. L., Ferreira, L. A. A., Ramos, G. L., da Silva, S. M. F., de Sousa, I. S., & Moreira, H. N. S. (2024) · Brazilian Journal of Health Review · doi:10.34119/bjhrv7n2-465 · Cited by 1
Rapid structural discrimination of IgG antibodies by multicharge-state collision-induced unfolding
Yin, Z., Du, M., Chen, D., Zhang, W., Huang, W., Wu, X., & Yan, S. (2021) · RSC Advances · doi:10.1039/d1ra06486j · Cited by 1
Molecular Assembly of Cyclic Dipeptide: Structure to Function
Ghosh, D., & Govindaraju, T. (2024) · doi:10.1002/9783527841264.ch10 · Cited by 1
Self-citationCysteine in Alzheimer's Disease
Ingale, S. P., Patil, R., & Upaganlawar, A. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-1317-0.ch013
A Brief Review on Alzheimer’s Disease
Suvitha, D., Dhivya, P., Saraswathy, T., & Ahamed Nisha, K. (2023) · International Journal of Pharmacy and Pharmaceutical Research · doi:10.25166/ijppr.2023.27.2.66
Santos, R. M., Tavares, C. A., Santos, T. M. R., Rasouli, H., & Ramalho, T. C. (2023) · Pharmaceuticals · doi:10.3390/ph16121653
Seiti, H., Larni-Fooeik, A., & Elkamel, A. (2024) · Studies in systems, decision and control · doi:10.1007/978-3-031-51719-8_9
New Prospects of Alternative Medicine from Plant Sources in Management of Alzheimer’s Disease
Kipkemoi, D. J. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006997
Understanding Alzheimer’s Disease: A Multidisciplinary Perspective
Akbarzadehmoallemkoalei, M., Yektakasmaei, M. P., Tabar, S. S. S., Zolfaghari, K., Noorikoloori, S., Niktalab, P., Rouzrokh, S., Sheykhzadeh, Z., Sanavi, M. A., Dozdouzan, M. A., et al. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_14
Gut Microbiome Changes in Preclinical Alzheimer’s Disease
Dissanayaka, S. U., Rainey‐Smith, S. R., Sohrabi, H. R., Jayasinghe, T. N., Ho, V., Jayasena, V., Taddei, K., Masters, C. L., Martins, R. N., & Fernando, W. M. A. D. B. (2026) · Nutrients · doi:10.3390/nu18152469 · Cited by 1
Metadata
- Authors
- Rajasekhar, K., & Govindaraju, T.
- Affiliations
- Jawaharlal Nehru Centre for Advanced Scientific Research (IN)
- Corresponding author
- Govindaraju, Thimmaiah
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2018
- Volume
- 8
- Issue
- 42
- Pages
- 23780-23804
- ISSN
- 2046-2069 (ISSN-L)
- PMC
- PMC9081849
- OpenAlex
- W2811135471
- Cited by
- 150
- References
- 158
- Citations by year
- 2026: 4 · 2025: 16 · 2024: 27 · 2023: 20 · 2022: 17 · 2021: 24 · 2020: 25 · 2019: 13 · 2018: 4
- FWCI
- 2.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- RSC Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Department of Science and Technology, Ministry of Science and Technology (DST/SJF/CSA-02/2015-2016)
- Sheikh Saqr Laboratory
- Jawaharlal Nehru Centre for Advanced Scientific Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Keywords
- Alzheimer's disease, Alzheimer's disease pathogenesis, early diagnosis, therapeutic interventions, drug development, neurotoxicity, clinical trials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
